# VINCI-AD: An Investigation of Transcutaneous Vagus Nerve Stimulation in Mild Cognitive Impairment.

> **NCT05514756** · NA · COMPLETED · sponsor: **Tallaght University Hospital** · enrollment: 40 (actual)

## Conditions studied

- Mild Cognitive Impairment
- Neurocardiogenic Syncope
- Memory Impairment
- Inflammatory Response
- Alzheimer Disease

## Interventions

- **DEVICE:** Active t-VNS
- **DEVICE:** Sham t-VNS
- **OTHER:** Baseline assessments

## Key facts

- **NCT ID:** NCT05514756
- **Lead sponsor:** Tallaght University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-01
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05514756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05514756, "VINCI-AD: An Investigation of Transcutaneous Vagus Nerve Stimulation in Mild Cognitive Impairment.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05514756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
